Of all the cancer specimens examined, 29 (18.9%) were negative for GINS2, 93 (60.8%) were weakly positive for GINS2 expression, 25 (16.3%) were positive for GINS2 expression and 6 (3.9%) were strongly positive for GINS2 expression (Figure 2E). This evidence concerns the gene GINS2 and cancer.